SNU-398 Cells

The SNU-398 cell line is derived from a hepatocellular carcinoma (HCC) of a human adult. This cell line is extensively used in liver cancer research to study the molecular mechanisms underlying hepatocarcinogenesis, tumor progression, and the development of therapeutic strategies. Hepatocellular carcinoma is a prevalent and deadly form of liver cancer, and SNU-398 cells provide a relevant model for investigating the genetic and epigenetic changes associated with this disease.
SNU-398 cells exhibit an epithelial morphology and express markers characteristic of liver cancer, such as alpha-fetoprotein (AFP) and cytokeratins. They harbor genetic mutations and alterations typical of HCC, including mutations in the TP53 gene, which is commonly associated with many cancers. Researchers utilize SNU-398 cells to explore various signaling pathways involved in liver cancer, such as the Wnt/β-catenin, PI3K/Akt, and MAPK pathways. These cells are also employed in drug screening assays to evaluate the efficacy of chemotherapeutic agents and targeted therapies, as well as in studies investigating resistance mechanisms to conventional treatments. The SNU-398 cell line’s importance in hepatocellular carcinoma research lies in its ability to model liver cancer biology and to contribute to the development of more effective therapies for liver cancer patients.